Alexandra Kupke
6PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 08, 2025
Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans.Alina Tscherne, Georgia Kalodimou, Alexandra Kupke
|May 27, 2023
Short- and Long-Interval Prime-Boost Vaccination with the Candidate Vaccines MVA-SARS-2-ST and MVA-SARS-2-S Induces Comparable Humoral and Cell-Mediated Immunity in Mice.Georgia Kalodimou, Sylvia Jany, Astrid Freudenstein
|Apr 23, 2022
Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein.Alexandra Kupke, Asisa Volz, Erik Dietzel
|Feb 15, 2022
Cyclosporin A Reveals Potent Antiviral Effects in Preclinical Models of SARS-CoV-2 Infection.Lucie Sauerhering, Irina Kuznetsova, Alexandra Kupke
|Aug 28, 2021
Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection.Sandro Halwe, Alexandra Kupke, Kanika Vanshylla
|Jun 24, 2021
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.Alina Tscherne, Jan Hendrik Schwarz, Cornelius Rohde
Pageof 1
Frequent Collaborators
5 joint publications
Cornelius Rohde
4 joint publications
Stephan Becker
3 joint publications
Sandro Halwe
3 joint publications
Gerd Sutter
2 joint publications
Alina Tscherne
2 joint publications
Verena Krähling
2 joint publications
Lucie Sauerhering
2 joint publications
Michelle Gellhorn Serra
2 joint publications
Michael Klüver
1 joint publications
Jan Hendrik Schwarz
